Value of (68)Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [(18)F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study

OBJECTIVES: The bombesin derivative RM2 is a GRPr antagonist with strong binding affinity to prostate cancer (PCa). In this study, the impact of [(68)Ga]Ga-RM2 positron emission tomography-computed tomography (PET-CT) for the detection of primary PCa was compared with that of [(18)F]FCH PET-CT and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Beheshti, Mohsen, Taimen, Pekka, Kemppainen, Jukka, Jambor, Ivan, Müller, Andre, Loidl, Wolfgang, Kähkönen, Esa, Käkelä, Meeri, Berndt, Mathias, Stephens, Andrew W., Minn, Heikki, Langsteger, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Urogenital
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755087/
https://www.ncbi.nlm.nih.gov/pubmed/35864350
http://dx.doi.org/10.1007/s00330-022-08982-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755087/
https://www.ncbi.nlm.nih.gov/pubmed/35864350
http://dx.doi.org/10.1007/s00330-022-08982-2

Ejemplares similares